Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    LSEG’s Lipper reviews transaction affecting fixed-income fund flow data

    July 25, 2026

    DeepSeek tells prospective investors of funding pause, Bloomberg News reports

    July 25, 2026

    AI firms want more data centers; Trump’s EPA may give neighbors less say

    July 25, 2026
    Facebook X (Twitter) Instagram
    Addison Markets
    • Home
    • USA
    • Europe
    • Business
    • Investing
    • Tech
    • Politics
    • Contact Us
    Addison Markets
    Home»Politics»Supreme Court lifts mail ban on abortion pill mifepristone
    Politics

    Supreme Court lifts mail ban on abortion pill mifepristone

    franperez66q@protonmail.comBy franperez66q@protonmail.comMay 4, 2026No Comments2 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email


    In this photo illustration, A packet of Mifepristone is seen at Wyoming’s last abortion clinic, Wellspring Center March 10, 2025 in Casper, Wyoming.

    Natalie Behring | Getty Images

    The U.S. Supreme Court on Monday temporarily lifted a lower court’s ban on the abortion pill mifepristone being sent through the mail.

    The administrative stay of the ban on mailing of mifepristone issued Friday by the 5th U.S. Circuit Court of Appeals will continue until at least 5 p.m. ET May 11, but could be extended after that.

    Supreme Court Justice Samuel Alito, who granted the temporary pause, gave the state of Louisiana until 5 p.m. Thursday to respond to requests that the 5th Circuit’s ruling be blocked as litigation over the issue plays out.

    Read more CNBC politics coverage

    Two drugmakers, Danco Laboratories and GenBioPro, over the weekend asked the Supreme Court to lift the ban on mifepristone being distributed through the mail.

    The drug is used in about two-thirds of all abortions in the United States.

    Louisiana had sued the Food and Drug Administration over its 2023 decision to lift a rule that mifepristone had to be administered in person.

    Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    franperez66q@protonmail.com
    • Website

    Related Posts

    Trump faces AI backlash from unions and data-center critics: Analysis

    July 25, 2026

    Andy Burnham to appear on Sunday with Laura Kuenssberg

    July 25, 2026

    Trump sued over new tariffs, experts say courts may scrap them

    July 24, 2026

    Trump defends DOJ subpoenas of NY Times reporters; Google also was targeted

    July 24, 2026

    UK complacent about war threat, warns BAE boss

    July 24, 2026

    Trump threatens EU tariffs over U.S. tech giant fines

    July 24, 2026
    Leave A Reply Cancel Reply

    Top Reviews
    Editors Picks

    LSEG’s Lipper reviews transaction affecting fixed-income fund flow data

    July 25, 2026

    DeepSeek tells prospective investors of funding pause, Bloomberg News reports

    July 25, 2026

    AI firms want more data centers; Trump’s EPA may give neighbors less say

    July 25, 2026

    Big Tech accused of stonewalling European social media researchers

    July 25, 2026
    © 2026 All right reserved
    • Privacy Policy
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.